-
公开(公告)号:US20100279970A1
公开(公告)日:2010-11-04
申请号:US12771289
申请日:2010-04-30
IPC分类号: A61K31/7076 , A61P27/06 , A61P27/02
CPC分类号: C07H19/16 , A61K31/7076
摘要: Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need thereof.
摘要翻译: 本文提供式I化合物,包含有效量的式I化合物的组合物和降低眼内压的方法,其包括向有需要的受试者施用有效量的式I化合物。
-
公开(公告)号:US07652028B2
公开(公告)日:2010-01-26
申请号:US11510484
申请日:2006-08-23
申请人: Prakash Jagtap , Duy-Phong Pham-Huu
发明人: Prakash Jagtap , Duy-Phong Pham-Huu
IPC分类号: A61K31/473 , C07D221/18
CPC分类号: C07D491/048 , C07D221/18 , C07D471/04 , C07D491/04 , C07D495/04
摘要: The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.
摘要翻译: 本发明涉及茚并异喹啉酮类似物,包含有效量的茚并异喹啉酮类似物和治疗或预防炎性疾病,再灌注损伤,糖尿病,糖尿病并发症,器官移植引起的再氧化损伤,缺血状况, 神经变性疾病,肾衰竭,血管疾病,心血管疾病,癌症,早产儿并发症,心肌病,视网膜病变,肾病,神经病,勃起功能障碍或尿失禁,包括向有需要的受试者施用有效量的茚并异喹啉酮类似物 。
-
公开(公告)号:US20090208506A1
公开(公告)日:2009-08-20
申请号:US12231797
申请日:2008-09-05
IPC分类号: A61K39/395 , C07K16/00 , C12N5/12 , C12N15/13 , C12N15/63
CPC分类号: C07K16/1235 , A61K2039/505 , A61K2039/545 , C07K16/1214 , C07K2317/21 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/92 , Y02A50/403 , Y02A50/407 , Y02A50/484
摘要: The present invention provides a novel class of monoclonal antibodies which have a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including, but not limited to, E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. The present invention further provides methods of treating inflammatory bowel disease (IBD) and methods of treating enterobacterial infections using anti-flagellin antibodies in humans, other animals and birds.
摘要翻译: 本发明提供了一种新型的单克隆抗体,其具有与来自各种革兰氏阴性细菌的鞭毛蛋白的高亲和力,广谱中和反应性,包括但不限于大肠杆菌,沙门氏菌,沙雷氏菌属,变形杆菌属,肠杆菌属,柠檬酸杆菌属,弯曲杆菌属 和假单胞菌属。 本发明还提供了治疗炎症性肠病(IBD)的方法和使用人,其他动物和鸟类中的抗鞭毛蛋白抗体治疗肠细菌感染的方法。
-
公开(公告)号:US20080262016A1
公开(公告)日:2008-10-23
申请号:US12140120
申请日:2008-06-16
申请人: Prakash Jagtap , Erkan Baloglu , John H. van Duzer , Csaba Szabo , Andrew L. Salzman , Aloka Roy , William Williams , Alexander Nivorozhkin
发明人: Prakash Jagtap , Erkan Baloglu , John H. van Duzer , Csaba Szabo , Andrew L. Salzman , Aloka Roy , William Williams , Alexander Nivorozhkin
IPC分类号: A61K31/4738 , C07D221/02 , C12N5/00 , A61P9/00 , A61P3/10 , A61P29/00 , A61K31/473
CPC分类号: C07D495/04 , A61K31/435 , A61K31/473 , A61K31/4741 , A61K31/4743 , A61K31/4745 , C07D221/18 , C07D471/04 , C07D491/04 , Y02A50/422
摘要: The invention provides novel classes of Isoquinoline Derivatives. Pharmaceutical compositions and methods of making and using the compounds, are also described.
摘要翻译: 本发明提供了新类别的异喹啉衍生物。 还描述了制备和使用化合物的药物组合物和方法。
-
65.
公开(公告)号:US07432369B2
公开(公告)日:2008-10-07
申请号:US11090447
申请日:2005-03-25
申请人: William Williams , Garry Southan
发明人: William Williams , Garry Southan
IPC分类号: C07B47/00 , C07D487/22
CPC分类号: C07D487/22 , C07F11/005 , C07F13/005 , C07F15/025
摘要: The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive species, erectile dysfunction due to surgery, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, a diabetic complication, cancer, a side effect of cancer chemotherapy, or a radiation-induced injury, or to prolong the half-life of an oxidation-prone compound, comprising administering to a subject in need thereof an effective amount of a Pyridyl-Substituted Porphyrin Compound.
摘要翻译: 本发明涉及吡啶基取代的卟啉化合物,包含有效量的吡啶基取代的卟啉化合物的组合物和用于治疗或预防由于暴露于反应性物质引起的损伤,由于手术引起的勃起功能障碍,肺部疾病,高氧,神经变性 疾病,肝脏疾病,心脏停搏期间的心肌损伤,炎症状况,再灌注损伤,缺血状况,心血管疾病,糖尿病,糖尿病并发症,癌症,癌症化疗的副作用或辐射诱发的损伤,或 延长易氧化化合物的半衰期,包括向有需要的受试者施用有效量的吡啶基取代的卟啉化合物。
-
公开(公告)号:US20070238694A1
公开(公告)日:2007-10-11
申请号:US11726572
申请日:2007-03-22
申请人: Andrew Salzman , Prakash Jagtap
发明人: Andrew Salzman , Prakash Jagtap
IPC分类号: A61K31/7076 , C07H19/20 , C07H19/19
摘要: The invention relates to Purine Compounds; compositions comprising an effective amount of a Purine Compound; and methods for reducing a subject's rate of metabolism or protecting a subject's heart against myocardial damage during cardioplegia; or for treating or preventing a cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, diabetes, a cellular proliferative disorder, a skin disorder, a radiation-induced injury, a wound or an inflammatory disease comprising administering an effective amount of a Purine Compound to a subject in need thereof.
摘要翻译: 本发明涉及嘌呤化合物; 包含有效量的嘌呤化合物的组合物; 以及减少受试者的代谢速率或保护受试者的心脏在心脏停搏期间对心肌损伤的方法; 或用于治疗或预防心血管疾病,神经障碍,缺血状况,再灌注损伤,肥胖症,消耗性疾病,糖尿病,细胞增殖性疾病,皮肤病,辐射诱导的损伤,伤口或炎性疾病 包括向有需要的受试者施用有效量的嘌呤化合物。
-
公开(公告)号:US07268143B2
公开(公告)日:2007-09-11
申请号:US10963293
申请日:2004-10-12
申请人: Prakash Jagtap , Csaba Szabo , Andrew L. Salzman , Aloka Roy , William Williams
发明人: Prakash Jagtap , Csaba Szabo , Andrew L. Salzman , Aloka Roy , William Williams
IPC分类号: A61K31/4745 , A61K31/5377 , C07D471/06 , C07D413/14
CPC分类号: C07D221/18 , C07D471/04 , C07D491/04 , C07D495/04
摘要: The invention provides novel classes of Isoquinoline Derivatives. Pharmaceutical compositions and methods of making and using the compounds, are also described.
摘要翻译: 本发明提供了新类别的异喹啉衍生物。 还描述了制备和使用化合物的药物组合物和方法。
-
公开(公告)号:US07217709B2
公开(公告)日:2007-05-15
申请号:US10788228
申请日:2004-02-26
申请人: Prakash Jagtap , Csaba Szabo
发明人: Prakash Jagtap , Csaba Szabo
IPC分类号: A61K31/5377 , A61K31/473 , C07D413/12 , C07D221/18
CPC分类号: C07H17/00 , C07D221/18 , C07D471/04 , C07D471/14 , C07D491/04 , C07D495/04 , C07D495/14
摘要: The invention relates to Tetracyclic Benzamide Derivatives; compositions comprising a Tetracyclic Benzamide Derivative; and methods for treating or preventing an inflammatory disease, a reperfusion disease, an ischemic condition, renal failure, diabetes, a diabetic complication, a vascular disease, or cancer, comprising administering to a subject in need thereof an effective amount of a Tetracyclic Benzamide Derivative.
-
公开(公告)号:US20070049555A1
公开(公告)日:2007-03-01
申请号:US11510484
申请日:2006-08-23
申请人: Prakash Jagtap , Duy-Phong Pham-Huu
发明人: Prakash Jagtap , Duy-Phong Pham-Huu
IPC分类号: A61K31/4743 , A61K31/4741 , A61K31/675
CPC分类号: C07D491/048 , C07D221/18 , C07D471/04 , C07D491/04 , C07D495/04
摘要: The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.
摘要翻译: 本发明涉及茚并异喹啉酮类似物,包含有效量的茚并异喹啉酮类似物和治疗或预防炎性疾病,再灌注损伤,糖尿病,糖尿病并发症,器官移植引起的再氧化损伤,缺血状况, 神经变性疾病,肾衰竭,血管疾病,心血管疾病,癌症,早产儿并发症,心肌病,视网膜病变,肾病,神经病,勃起功能障碍或尿失禁,包括向有需要的受试者施用有效量的茚并异喹啉酮类似物 。
-
公开(公告)号:US07087631B2
公开(公告)日:2006-08-08
申请号:US10620619
申请日:2003-07-17
申请人: Alex Nivorozhkin , John Van Duzer , Garry Southan , Siya Ram , Qi Zeng
发明人: Alex Nivorozhkin , John Van Duzer , Garry Southan , Siya Ram , Qi Zeng
IPC分类号: A61K31/41 , C07D257/04
CPC分类号: C07D257/04 , C07D401/10 , C07D401/12 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/12 , C07D417/12
摘要: The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.
摘要翻译: 本发明涉及5-芳基四唑化合物,包含有效量的5-芳基四唑化合物的组合物,以及用于治疗有需要的动物中炎性疾病,再灌注疾病或高尿酸血症的方法,其包括向所述动物施用有效量 的5-芳基四唑化合物。
-
-
-
-
-
-
-
-
-